Literature DB >> 201664

Anti-complement immunofluorescence test for antibodies to human cytomegalovirus.

J D Kettering, N J Schmidt, D Gallo, E H Lennette.   

Abstract

An anti-complement immunofluorescence (ACIF) test that detects human cytomegalovirus (CMV) antigen in the nuclei of infected cells was used for assay of CMV antibodies in human sera. Various factors influencing the sensitivity and specificity of the ACIF test system were investigated, and results were applied to the development of a procedure which could be completed in a relatively short length of time and gave reproducible results. Results obtained in the ACIF test were compared with those obtained in complement fixation, indirect hemagglutination, and neutralization tests, and the ACIF test was shown to be suitable for detection of significant antibody titer rises and stationary levels of CMV antibody. Heterotypic antibody responses were not seen with sera from other human herpesvirus infections. The nonspecific cytoplasmic staining that occurs in indirect immunofluorescence tests for CMV did not occur in the ACIF system, and sera that were anti-complementary in complement fixation tests could be examined satisfactorily by ACIF. Thus, the test is a valuable supplemental or back-up procedure for the serodiagnosis of CMV infection.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 201664      PMCID: PMC274835          DOI: 10.1128/jcm.6.6.627-632.1977

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens.

Authors:  B M Reedman; J Hilgers; F Hilgers; G Klein
Journal:  Int J Cancer       Date:  1975-04-15       Impact factor: 7.396

2.  Indirect fluorescent-antibody test for human cytomegalovirus infection in the absence of interfering immunoglobulin G receptors.

Authors:  N S Swack; F J Michalski; A Baumgarten; G D Hsiung
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

3.  Antisera to human cytomegalovirus produced in hamsters: reactivity in radioimmunoassay and other antibody assay systems.

Authors:  B Forghani; N J Schmidt; E H Lennette
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

4.  Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells.

Authors:  N J Schmidt; J Dennis; E H Lennette
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

5.  False negative and prozone reactions in tests for antibodies to Epstein-Barr virus-associated nuclear antigen.

Authors:  W Henle; A Guerra; G Henle
Journal:  Int J Cancer       Date:  1974-06-15       Impact factor: 7.396

6.  The development of immunofluorescent antibodies as compared with complement-fixing and virus-neutralizing antibodies in human cytomegalovirus infection.

Authors:  E S Spencer; H K Andersen
Journal:  Scand J Infect Dis       Date:  1972

7.  Indirect hemagglutination test for detection of antibodies to Cytomegalovirus.

Authors:  M T Bernstein; J A Stewart
Journal:  Appl Microbiol       Date:  1971-01

8.  A study of complement-fixing, immunofluorescent, and neutralizing antibodies in human cytomegalovirus infections.

Authors:  U Krech; M Jung; W Sonnabend
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1971-06

9.  Micro indirect hemagglutination test for Cytomegalovirus.

Authors:  D A Fuccillo; F Moder; R G Traub; S Hensen; J L Sever
Journal:  Appl Microbiol       Date:  1971-01

10.  Herpes simplex virus nuclear nonvirion antigens detected by anticomplement immunofluorescence.

Authors:  G Tarro; G G Giordano; A Tripodi; R Cerra; M Di Gioia; A Battista; R Smeraglia
Journal:  Tumori       Date:  1976 Nov-Dec
View more
  17 in total

Review 1.  Herpesviruses.

Authors:  M C Timbury; E Edmond
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

2.  Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence.

Authors:  R S Blumberg; E G Sandstrom; T J Paradis; D N Neumeyer; M G Sarngadharan; K L Hartshorn; R E Byington; M S Hirsch; R T Schooley
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

3.  Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation.

Authors:  S Mackinnon; A K Burnett; R J Crawford; S Cameron; B G Leask; R G Sommerville
Journal:  J Clin Pathol       Date:  1988-09       Impact factor: 3.411

4.  Natural killing of fibroblasts infected with low-passage clinical isolates of human cytomegalovirus.

Authors:  S Bandyopadhyay; S H Oh; S Michelson; D S Miller; J L Virelizier; S E Starr
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

5.  Elimination of Fc receptor binding of human immunoglobulin G in immunofluorescence assays for herpes simplex virus antibodies.

Authors:  D Gallo
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

6.  Improved immunofluorescence antigens for detection of immunoglobulin M antibodies to Epstein-Barr viral capsid antigen and antibodies to Epstein-Barr virus nuclear antigen.

Authors:  D Gallo; K H Walen; J L Riggs
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

7.  Anticomplement immunofluorescence test that uses isolated fibroblast nuclei for detection of antibodies to human cytomegalovirus.

Authors:  L Mintz; R C Miner; A S Yeager
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

8.  Application of a human osteogenic sarcoma cell culture for detection of human cytomegalovirus antibody by immunofluorescence tests.

Authors:  T Furukawa; R Herold; P Zolnick; S A Plotkin
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

9.  Evaluation of the anticomplement immunofluorescence test for detection of antibody to varicella-zoster virus.

Authors:  C M Preissner; S P Steinberg; A A Gershon; T F Smith
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

10.  Detection of antibodies to pre-early nuclear antigen and immediate-early antigens in patients immunized with cytomegalovirus vaccine.

Authors:  A D Friedman; S Michelson; S A Plotkin
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.